GP-Act III Acquisition Corp. (NASDAQ:GPATW – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totaling 2,294 shares, a drop of 47.8% from the September 30th total of 4,397 shares. Based on an average daily trading volume, of 13,742 shares, the short-interest ratio is currently 0.2 days.
GP-Act III Acquisition Stock Down 21.1%
Shares of NASDAQ GPATW traded down $0.02 during trading on Friday, hitting $0.06. The company had a trading volume of 239 shares, compared to its average volume of 22,263. The stock has a fifty day simple moving average of $0.10 and a two-hundred day simple moving average of $0.18. GP-Act III Acquisition has a fifty-two week low of $0.03 and a fifty-two week high of $0.43.
About GP-Act III Acquisition
GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify and complete a merger, capital stock exchange, asset acquisition, or similar business combination with one or more operating companies.
As a blank-check company, GP-Act III Acquisition Corp. does not currently operate a commercial business or offer products and services of its own. Its activities are focused primarily on evaluating potential acquisition targets and pursuing a transaction that would result in a publicly traded operating company.
GPATW represents the company’s publicly traded warrants, which are securities that may provide holders with the right to purchase shares under specified terms.
Recommended Stories
- Five stocks we like better than GP-Act III Acquisition
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
